EZH2 is overexpressed during prostate cancer progression [5, 6] and promotes proliferation, invasion, tumor formation, and metastasis of prostate cancer cells, and is considered to be involved in the progression to advanced disease [7-11]. Here, EZH2 is linked to Familial prostate cancer.